{
    "organizations": [],
    "uuid": "dad9e36da9d20d59a54138f8f27e046ecadd5980",
    "author": "Cara Lombardo",
    "url": "https://www.wsj.com/articles/pfizer-revenue-growth-stalls-1525174796",
    "ord_in_thread": 0,
    "title": "Pfizer Revenue Growth Stalls",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Pfizer Inc.â€™s revenue was little changed in its latest quarter as the pharmaceutical company examines the future of its consumer-health business.\nPfizer said Tuesday its first-quarter revenue increased 1% from a year ago to $12.91 billion, less than the $13.13 billion analysts expected. Revenue increased in its innovative health unit, which is slightly more than half the business and includes its consumer-health brands such as Advil, Chapstick and Centrum vitamins. But it decreased in its essential health unit, which the... To Read the Full Story Subscribe Sign In",
    "published": "2018-05-01T15:39:00.000+03:00",
    "crawled": "2018-05-01T16:03:11.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pfizer",
        "revenue",
        "little",
        "changed",
        "latest",
        "quarter",
        "pharmaceutical",
        "company",
        "examines",
        "future",
        "business",
        "pfizer",
        "said",
        "tuesday",
        "revenue",
        "increased",
        "year",
        "ago",
        "billion",
        "less",
        "billion",
        "analyst",
        "expected",
        "revenue",
        "increased",
        "innovative",
        "health",
        "unit",
        "slightly",
        "half",
        "business",
        "includes",
        "brand",
        "advil",
        "chapstick",
        "centrum",
        "vitamin",
        "decreased",
        "essential",
        "health",
        "unit",
        "read",
        "full",
        "story",
        "subscribe",
        "sign"
    ]
}